Skip to main content
Gufic BioSciences Ltd. logo

Gufic BioSciences Ltd. — Investor Relations & Filings

Ticker · GUFICBIO ISIN · INE742B01025 LEI · 3358003C6YDH6EIDBP63 BSE.NS Manufacturing
Open in API
Filings indexed 1,192 across all filing types
Latest filing 2025-04-14 Legal Proceedings Report
Country IN India
Listing BSE.NS GUFICBIO

About Gufic BioSciences Ltd.

https://gufic.com/

Gufic BioSciences Ltd. focuses on the research, development, and large-scale manufacturing of pharmaceutical formulations and active pharmaceutical ingredients. The organization is distinguished by its specialized expertise in lyophilization technology, operating extensive facilities for the production of freeze-dried injectables. Its product portfolio encompasses a wide range of therapeutic areas, including critical care, infertility, oncology, and gastroenterology. In addition to conventional medicine, the company develops proprietary herbal and ayurvedic formulations through integrated scientific research. Gufic emphasizes advanced drug delivery systems and maintains a significant presence in the production of antibiotics, antifungal agents, and cardiac medications. The company serves a global clientele by providing high-quality generic and specialty healthcare solutions.

Recent filings

Filing Released Lang Actions
Intimation of Appeal filed against Assessment Order passed by the Assessment Unit, Income Tax Department is attached herewith.
Legal Proceedings Report Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) informing them about the filing of an appeal against an Income Tax Department assessment order. It references regulatory compliance under SEBI Listing Regulations and provides details about the litigation and expected financial implications. The document is short (2805 characters) and serves as an announcement of a legal proceeding rather than a detailed report or financial statement. It does not contain financial data, earnings, management discussion, or audit information. It fits best under Legal Proceedings Report (LTR) as it updates on a significant legal matter involving the company.
2025-04-14 English
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Legal Proceedings Report Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding the filing of an appeal against an income tax assessment order. It references regulatory compliance under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 30, which pertains to material event disclosures. The content details a legal proceeding (an appeal against an income tax assessment) and its financial implications. The document is short (2805 characters) and serves as an announcement of a legal proceeding rather than a full legal report or audit. It does not contain financial statements or detailed financial analysis. Therefore, it fits best under the category of Legal Proceedings Report (LTR), which covers updates on significant lawsuits or regulatory actions involving the company.
2025-04-14 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 100% confidence The document is a certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2025. It is a compliance certificate from the Registrar and Share Transfer Agent confirming dematerialisation activities and securities status for the quarter. The document is short (3202 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is not an announcement of a report but a certificate under a specific regulatory provision. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and regulatory confirmations.
2025-04-08 English
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2025 is attached herewith.
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming dematerialisation activities for the quarter ended March 31, 2025. It is addressed to stock exchanges and signed by the company secretary and the registrar and share transfer agent. The document is short (3202 characters) and serves as a compliance certificate rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or audit information. It is a regulatory compliance certificate related to share dematerialisation and does not fit into categories like Annual Report, Interim Report, or Earnings Release. Therefore, it best fits under Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory compliance documents that do not fit other categories.
2025-04-08 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the closure of the trading window pursuant to SEBI regulations ahead of the announcement of audited financial results for the quarter and financial year ended March 31, 2025. It does not contain any financial data or results itself, nor does it present or discuss the financial report. Instead, it is an announcement related to compliance and insider trading restrictions before the financial results are published. The document length is short (1570 characters), and it serves as a notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-03-27 English
Intimation of Closure of Trading Window is attached herewith
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the closure of the trading window pursuant to SEBI regulations ahead of the announcement of audited financial results for the quarter and financial year ended March 31, 2025. It does not contain any financial data, results, or detailed report content itself. It is an announcement related to compliance and insider trading restrictions before the financial results are declared. The document length is short (1570 characters) and it serves as a notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS) as a compliance-related announcement rather than an actual financial report or earnings release.
2025-03-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.